NRAS Q61K 的晶体结构在 II 开关附近有一个联结体诱导的口袋
Teklab Gebregiworgis1, Jonathan Yui-Lai Chan2, Douglas A Kuntz2
1Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario M5G 1L7, Canada; Department of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, Ontario N6A 5C1, Canada; Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, Ontario N6A 5W9, Canada.
研究人员揭示了NRAS Q61K突变蛋白的新型结合部位,为NRAS驱动的癌症提供了新的治疗点. 这一发现推动了对突变NRAS的特定抑制剂的开发,这是一种以前无法治疗的癌症标.
科学领域:
- 分子生物学分子生物学
- 结构生物学 结构生物学
- 在瘤学瘤学.
背景情况:
- RAS蛋白 (KRAS,HRAS,NRAS) 是细胞信号的关键调节者,它们的突变驱动各种癌症.
- NRAS突变在皮肤和血液恶性瘤中普遍存在,但与KRAS和HRAS相比,在结构上研究较少.
- 尽管几十年来被认为是不可抗药的,但有针对性的RAS抑制剂正在出现,这凸显了对异型特异性策略的需求.
研究的目的:
- 将NRAS Q61K突变体的晶体结构以其活性,与GTP结合的形式呈现.
- 确定针对NRAS突变的治疗干预潜在的新型结合部位.
- 了解NRAS-Q61K中受损GTP水解的机制.
主要方法:
- 使用X射线晶体学来确定与GTP结合的NRAS Q61K突变体的结构.
- 结构分析的重点是活动现场和周边地区,特别是在II开关附近.
- 对GTP水解的生物化学见解来自于已解决的催化部位.
主要成果:
- 在配体结合时,在NRAS Q61K的交换机II区域附近发现了一种新的,以前未被描述的口袋.
- 晶体结构提供了GTP结合的NRAS Q61K活性部位的详细视图.
- 该结构为NRAS-Q61K中观察到的停滞的GTP水解提供了机制性的解释.
结论:
- 鉴定到的"口袋"是开发针对突变NRAS的特定抑制剂的潜在可用药物标.
- 这些结构信息对于设计下一代NRAS向癌症疗法至关重要.
- 对NRAS结构生物学的进一步研究可以为NRAS突变癌症开辟新的治疗途径.
更多相关视频
15:05Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
09:19Strategic Screening and Characterization of the Visual GPCR-mini-G Protein Signaling Complex for Successful Crystallization
Published on: March 16, 2020
相关概念视频
The Ras Gene
Ras is a...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Ligand Binding and Linkage
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
